𝔖 Bobbio Scriptorium
✦   LIBER   ✦

I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat

✍ Scribed by T. Nomura; O. Honmou; K. Harada; K. Houkin; H. Hamada; J.D. Kocsis

Book ID
116787222
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
529 KB
Volume
136
Category
Article
ISSN
0306-4522

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intravenous administration of glial cell
Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat
✍ Yoshifumi Horita; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 498 KB

## Abstract Intravenous administration of human mesenchymal stem cells (hMSCs) prepared from adult bone marrow has been reported to ameliorate functional deficits after cerebral artery occlusion in rats. Several hypotheses to account for these therapeutic effects have been suggested, and current th

Glial cell line-derived neurotrophic fac
Glial cell line-derived neurotrophic factor–secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 456 KB πŸ‘ 1 views

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem